Back to top
more

Patterson Companies (PDCO)

(Delayed Data from NSDQ)

$20.27 USD

20.27
689,626

-0.01 (-0.05%)

Updated Oct 8, 2024 03:59 PM ET

After-Market: $20.27 0.00 (0.00%) 7:58 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy23.68%
2Buy17.55%
3Hold9.21%
4Sell4.93%
5Strong Sell2.36%
S&P50010.96%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

3-Hold of 5     3    

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

A Value F Growth B Momentum C VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Bottom 30% (176 out of 252)

Industry: Medical - Dental Supplies

Better trading starts here.

Zacks News

PDCO or MMSI: Which Is the Better Value Stock Right Now?

PDCO vs. MMSI: Which Stock Is the Better Value Option?

Cardinal Health (CAH) Q4 Earnings and Revenues Beat Estimates

Cardinal (CAH) delivered earnings and revenue surprises of 4.73% and 2%, respectively, for the quarter ended June 2023. Do the numbers hold clues to what lies ahead for the stock?

Nevro's (NVRO) Latest Launch to Customize Chronic Pain Treatment

Nevro's (NVRO) HFX Connect system is expected to treat individual patients per their requirements with 35 pre-programmed customizable plans.

Here's Why Investors Should Retain Abbott (ABT) Stock Now

Investors are optimistic about Abbott (ABT) on its strategic expansion in the global market and recovery within the Nutrition segment.

Reasons to Add Patterson Companies (PDCO) to Your Portfolio Now

Investors remain optimistic about Patterson Companies (PDCO) on the back of its broad product line.

Rockwell Medical (RMTI) to Post Q2 Earnings: What's in Store?

Robust product demand and cost-saving initiatives are likely to have boosted Rockwell Medical's (RMTI) second quarter's top line.

Alcon (ALC) to Report Q2 Earnings: What's in the Cards?

Alcon (ALC) might have benefitted from the high win rate of Argos Biometer in the second quarter.

How to Find Strong Medical Stocks Slated for Positive Earnings Surprises

The Zacks Earnings ESP is a great way to find potential earnings surprises. Why investors should take advantage now.

Indrajit Bandyopadhyay headshot

3 Medical Product Stocks Set to Outpace Q2 Earnings Estimates

Medical Product companies' results are likely to reflect base business recovery on a year-over-year basis. Let's see how NEOG, PDCO and DH are poised ahead of their earnings release.

ScPharmaceuticals, Inc. (SCPH) Reports Q2 Loss, Tops Revenue Estimates

scPharmaceuticals, Inc. (SCPH) delivered earnings and revenue surprises of 2.70% and 5.68%, respectively, for the quarter ended June 2023. Do the numbers hold clues to what lies ahead for the stock?

Why Patterson Cos. (PDCO) is Poised to Beat Earnings Estimates Again

Patterson Cos. (PDCO) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.

Is a Beat Likely for Cardinal Health (CAH) in Q4 Earnings?

Cardinal Health's (CAH) fiscal fourth-quarter 2023 results are expected to reflect solid performance in the Pharmaceutical segment.

Merit Medical (MMSI) Completes Enrollment in WRAPSODY Study

Merit Medical (MMSI) is evaluating its device for treating stenosis/occlusion, WRAPSODY, in a pivotal study on patients undergoing hemodialysis. Primary data from the study is expected after six months.

Patterson Cos. (PDCO) Gains As Market Dips: What You Should Know

In the latest trading session, Patterson Cos. (PDCO) closed at $33.37, marking a +0.45% move from the previous day.

SmileDirectClub (SDC) Reports Q2 Loss, Misses Revenue Estimates

SmileDirectClub (SDC) delivered earnings and revenue surprises of -8.33% and 1.53%, respectively, for the quarter ended June 2023. Do the numbers hold clues to what lies ahead for the stock?

Reasons to Add The Cooper Companies (COO) to Your Portfolio

The Cooper Companies (COO) continues to benefit from strength in its business segments. Its acquisitions are likely to drive the top line further.

Charles River (CRL) to Report Q2 Earnings: What's in Store?

Continued global demand for research models and associated services' strong DSA segment performance is likely to have driven Charles River's (CRL) Q2 revenues.

Patterson Cos. (PDCO) Up 3.5% Since Last Earnings Report: Can It Continue?

Patterson Cos. (PDCO) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

Are Medical Stocks Lagging GSK PLC Sponsored ADR (GSK) This Year?

Here is how GSK (GSK) and Patterson Cos. (PDCO) have performed compared to their sector so far this year.

Patterson Cos. (PDCO) Just Flashed Golden Cross Signal: Do You Buy?

Good things could be on the horizon when a stock surpasses the 20-day simple moving average. How should investors react?

Patterson Cos. (PDCO) Outpaces Stock Market Gains: What You Should Know

Patterson Cos. (PDCO) closed at $32.53 in the latest trading session, marking a +1.43% move from the prior day.

Patterson Cos. (PDCO) is a Top-Ranked Value Stock: Should You Buy?

Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.

Indrajit Bandyopadhyay headshot

5 Stocks to Buy From the Prospering Dental Supplies Industry

Here we discuss five stocks from the Dental Supplies industry that are likely to create wealth for investors. These include WST, ALGN, COO, XRAY and PDCO.

Abhinab Dasgupta headshot

3 Healthcare Stocks to Buy Amid Market Volatility

Patterson (PDCO), Perrigo (PRGO) and GSK are three healthcare stocks that can lend solidity to one's portfolio today and provide big returns in the foreseeable future.

PDCO or MMSI: Which Is the Better Value Stock Right Now?

PDCO vs. MMSI: Which Stock Is the Better Value Option?